The availability of a functional tumor targeting T-cell repertoire determines the anti-tumor efficiency of combination therapy with anti-CTLA-4 and anti-4-1BB antibodies

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

It has previously been found that combination therapy with anti-CTLA-4 and anti-4-1BB antibodies may enhance tumor immunity. However, this treatment is not efficient against all tumors, and it has been suggested that variations in tumor control may reflect differences in the immunogenicity of different tumors. In the present report, we have formally tested this hypothesis. Comparing the efficiency of combination antibody therapy against two antigenically distinct variants of the B16.F10 melanoma cell line, we observed that antibody therapy delayed the growth of a variant expressing an exogenous antigen (P
TidsskriftP L o S One
Udgave nummer6
Antal sider5
StatusUdgivet - 2013

Antal downloads er baseret på statistik fra Google Scholar og

Ingen data tilgængelig

ID: 46384334